Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
703.00
711.27
600.76
447.26
711.86
685.90
540.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
703.00
711.27
600.76
447.26
711.86
685.90
540.37
Raw Material Cost
590.49
566.88
512.21
337.15
568.18
577.71
488.75
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
19.11
18.71
19.19
17.36
18.62
23.97
27.09
Selling and Distribution Expenses
53.38
63.84
52.42
58.49
66.56
57.93
48.16
Other Expenses
0.53
0.31
1.22
0.58
1.81
-1.10
0.99
Total Expenditure (Excl Depreciation)
668.33
652.55
596.05
418.84
671.44
648.58
573.94
Operating Profit (PBDIT) excl Other Income
34.7
58.7
4.699999999999999
28.4
40.4
37.3
-33.6
Other Income
31.19
-1.23
11.93
4.82
11.22
12.97
11.53
Operating Profit (PBDIT)
108.21
108.40
57.46
83.52
100.69
98.19
14.57
Interest
19.11
18.71
19.19
17.36
18.62
23.97
27.09
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.02
Gross Profit (PBDT)
112.51
144.39
88.55
110.10
143.68
108.18
51.62
Depreciation
61.57
61.57
65.51
65.51
57.59
57.59
57.65
Profit Before Tax
27.52
28.11
-27.23
0.65
24.49
16.63
-70.15
Tax
6.91
6.82
-11.95
-0.94
7.63
1.99
-13.63
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
18.98
20.95
-18.60
-0.31
14.79
14.34
-58.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
18.98
20.95
-18.60
-0.31
14.79
14.34
-58.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.14
-0.14
-0.29
0.01
0.41
-0.08
-0.27
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
19.11
20.82
-18.89
-0.30
15.20
14.27
-58.35
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,477.33
2,575.09
2,557.89
2,600.45
2,626.07
2,642.90
2,628.16
Earnings per share (EPS)
0.04
0.05
-0.04
-0.0
0.03
0.03
-0.13
Diluted Earnings per share
0.04
0.05
-0.04
-0.0
0.03
0.03
-0.13
Operating Profit Margin (Excl OI)
2.2%
6.76%
-3.33%
2.95%
4.48%
4.03%
-10.11%
Gross Profit Margin
12.67%
12.61%
6.37%
14.79%
11.53%
10.82%
-2.31%
PAT Margin
2.7%
2.95%
-3.1%
-0.07%
2.08%
2.09%
-10.75%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -1.25% vs 3.44% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 25.66% vs 43.40% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is -13.97% vs 5.67% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 2.69% vs -16.22% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Zhejiang Starry Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
703.00
0
703.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
703.00
0
703.00
Raw Material Cost
590.49
0
590.49
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
19.11
0
19.11
Selling and Distribution Expenses
53.38
0
53.38
Other Expenses
0.53
0.00
0.53
Total Expenditure (Excl Depreciation)
668.33
0
668.33
Operating Profit (PBDIT) excl Other Income
34.67
0.00
34.67
Other Income
31.19
0
31.19
Operating Profit (PBDIT)
108.21
0
108.21
Interest
19.11
0
19.11
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
112.51
0
112.51
Depreciation
61.57
0
61.57
Profit Before Tax
27.52
0
27.52
Tax
6.91
0
6.91
Provisions and contingencies
0
0
0.00
Profit After Tax
18.98
0
18.98
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
18.98
0
18.98
Share in Profit of Associates
0
0
0.00
Minority Interest
0.14
0
0.14
Other related items
0.00
0.00
0.00
Consolidated Net Profit
19.11
0
19.11
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,477.33
0
2,477.33
Earnings per share (EPS)
0.04
0
0.04
Diluted Earnings per share
0.04
0
0.04
Operating Profit Margin (Excl OI)
2.20%
0%
0.00
2.20%
Gross Profit Margin
12.67%
0%
0.00
12.67%
PAT Margin
2.70%
0%
0.00
2.70%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 70.30 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -1.17% vs 18.39% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -1.25% vs 3.44% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.91 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -8.17% vs 210.05% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 25.66% vs 43.40% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.70 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -29.74% vs 140.88% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -13.97% vs 5.67% in Jun 2025
Quarterly - Interest
Interest 1.91 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 2.14% vs -2.60% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 2.69% vs -16.22% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.20%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
